Abstract
Several coating techniques for extracorporeal circulation have been developed to reduce the systemic inflammatory response during cardiopulmonary bypass (CPB). We compared the clinical effectiveness and biocompatibility of poly-2-methoxyethylacrylate (PMEA)- and heparin-coated CPB circuits in total aortic arch replacement (TAR) with the prolonged use of the bypass technique. Twenty patients who underwent elective TAR were divided randomly into two equal groups: group P (n = 10) to use PMEA-coated circuits and group H (n = 10) to use heparin-coated circuits. Clinical outcomes, hematological variables, and acute phase inflammatory response were analyzed perioperatively. Demographic, CPB, and clinical outcome data were similar for both groups. Hemoglobin and platelet count showed similar time-course curves. However, the amount of platelet products transfused intraoperatively was significantly larger in group H (group P 26.0 ± 7.0 units; group H 33.0 ± 6.7 units, p = 0.04). Total protein, and albumin levels were significantly higher in group P during and after the operation (total protein, p = 0.04; albumin, p = 0.02). The use of PMEA-coated circuit is associated with retainment of perioperative plasma proteins levels and may help to reduce transfusion of platelet products in TAR in comparison with the heparin-coated circuit.
Similar content being viewed by others
References
Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552–9.
Ito H, Hamano K, Gohra H, Katoh T, Fujimura Y, Tsuboi H, Esato K. Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today. 1997;27:220–5.
Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE. Reduced complement activation with heparin- coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg. 1992;103:806–13.
Gu YJ, van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CR. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:917–22.
Lazar HL, Zhang X, Hamasaki T, Memmelo CA, Treanor P, Rivers S, Aldea GS, Bernard SA, Shemin RJ. Heparin-bonded circuits decrease myocardial ischemic damage. An experimental study. Ann Thorac Surg. 1997;63:1701–5.
te-Velthuis H, Baufreton C, Jansen PG, Thijs CM, Hack CE, Sturk A, Wildevuur CR, Loisance DY. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations. J Thorac Cardiovasc Surg. 1997;114:117–22.
Moen O, Hogasen K, Fosse E, Dregelid E, Brockmeier V, Venge P, Harboe M, Mollnes TE. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1997;63:105–11.
Matsuo M, Kitada H, Iida H, Okamoto T. An experimental study in prolonged use of heparin-coated cardiopulmonary bypass circuits. Jpn J Extra-Copreal Technol. 2000;27:57–9.
Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg. 1999;16:342–50.
Hazlewood CF, Nichols BL, Chamberlain NF. Evidence for the existence of a minimum of two phases of ordered water in skeletal muscle. Nature. 1969;222:747–50.
Anzai T, Okumura A, Kawaura M, Yokoyama K, Oshiyama H, Kido T, Nojiri C. Evaluation of the biocompatibility of an in vitro test using a poly2 methoxyethylacrylate coated oxygenator. Jinko Zoki. 2000;29:73–9.
Suzuki Y, Daitoku K, Minakawa M, Fukui K, Fukuda IA, Kawaura M, Yokoyama K, Oshiyama H, Kido K, Nojiri C. Poly-2-methoxyethylacrylate-coated bypass circuits reduce activation of coagulation system and inflammatory response in congenital cardiac surgery. Jpn J Artif Organs. 2008;11:111–6.
Gunaydin S, Farsak B, Kocakulak M, Sari T, Yorgancioglu C, Zorlutuna Y. Clinical performance and biocompatibility of poly (2-methoxyethylacrylate)-coated extracorporeal circuits. Ann Thorac Surg. 2002;74:819–24.
Ikuta T, Fujii H, Shibata T, Hattori K, Hirai H, Kumano H, Suehiro S. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg. 2004;77:1678–83.
Suhara H, Sawa Y, Nishimura M, Oshiyama H, Yokoyama K, Saito N, Matsuda H. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann Thorac Surg. 2001;71:1603–8.
Hazama S, Eishi K, Yamachika S, Noguchi M, Ariyoshi T, Takai H, Odate T, Matsukuma S, Onohara D, Yanatori M. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2 methoxyethylacrylate-coated circuits). Ann Thorac Cardiovasc Surg. 2004;10:90–6.
Kutay V, Noyan T, Ozcan S, Melek Y, Ekim H, Yakut C. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits. J Card Surg. 2006;21:572–7.
Izuha H, Hattori M, Igari T, Wakamatsu D, Watanabe M, Yokoyama H. Changes in platelet aggregation during cardiopulmonary bypass: comparison of poly-2-methoxyethylacrylate and heparin as a circuit coating material. J Artif Organs. 2005;8:41–6.
Saito N, Motoyama S, Sawamoto J. Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass. Artif Organs. 2000;24:547–54.
Tanaka M, Motomura T, Kawada M, Anzai T, Kasori Y, Shiroya T, Shimura K, Onishi M, Mochizuki A. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA) relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials. 2000;21:1471–81.
Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, Mantovani A. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med. 2001;29:1404–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Yoshikatsu Saiki received a research grant from Terumo Corporation, Tokyo, Japan. The other authors declare that they have no conflict of interest.
Additional information
K. Hosoyama and K. Ito contributed to this manuscript equally.
Rights and permissions
About this article
Cite this article
Hosoyama, K., Ito, K., Kawamoto, S. et al. Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery. J Artif Organs 19, 233–240 (2016). https://doi.org/10.1007/s10047-016-0887-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-016-0887-8